Arcapta and C1 esterase inhibitor recombinant Intravenous
Determining the interaction of Arcapta and C1 esterase inhibitor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indacaterol
Brand name: Arcapta Neohaler
Synonyms: Arcapta Neohaler
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Arcapta-C1 esterase inhibitor, human Intravenous
- Arcapta-C1 Inhibitor (Human)
- Arcapta-C1 Inhibitor (Human) (Berinert)
- Arcapta-C1 Inhibitor (Human) (Cinryze)
- Arcapta-C1 Inhibitor (Human) (Haegarda)
- Arcapta-C1 Inhibitor (Recombinant)
- C1 esterase inhibitor recombinant Intravenous-Arcapta Neohaler
- C1 esterase inhibitor recombinant Intravenous-Ardeparin Subcutaneous
- C1 esterase inhibitor recombinant Intravenous-Aredia
- C1 esterase inhibitor recombinant Intravenous-Arestin
- C1 esterase inhibitor recombinant Intravenous-Arestin eent
- C1 esterase inhibitor recombinant Intravenous-Arestin mucous membrane powder